Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Binder

Showing results (351-360 of 399) with videos related to

Pageof 40
Sort By:
Neuro-Oncology Advances|March 7, 2020
Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastomaSeyed Ali Nabavizadeh, Jeffrey B Ware, Samantha Guiry, et al.
Cancer Immunology Research|June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cellsShujing Liu, Alain H Rook, Alexander C Huang, et al.
Cancer Immunology Research|April 30, 2014
NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approachesGilson S Baia, Otavia L Caballero, Janelle S Y Ho, et al.
Cancer Medicine|December 5, 2022
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/dayMatthew H Taylor, Sophie Leboulleux, Yury Panaseykin, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE<sub>2</sub>-receptor E-type 4 (EP4), in patients with advanced cancersDavid S Hong, Aparna Parikh, Geoffrey I Shapiro, et al.
JCO Precision Oncology|September 4, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for GlioblastomaErica L Carpenter, Jacob E Till, Dominique Ballinger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2022
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumorsYibo Yin, Jesse L Rodriguez, Nannan Li, et al.
Scientific Reports|February 28, 2024
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approachJun Guo, Anahita Fathi Kazerooni, Erik Toorens, et al.
Pain|May 16, 2006
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference valuesR Rolke, R Baron, C Maier, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 16, 2019
Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2T Reiff, H H Eckstein, U Mansmann, et al.
Pageof 40

Showing results (351-360 of 399) with videos related to

Sort By:
Pageof 40
Neuro-Oncology Advances|March 7, 2020
Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastomaSeyed Ali Nabavizadeh, Jeffrey B Ware, Samantha Guiry, et al.
Cancer Immunology Research|June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cellsShujing Liu, Alain H Rook, Alexander C Huang, et al.
Cancer Immunology Research|April 30, 2014
NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approachesGilson S Baia, Otavia L Caballero, Janelle S Y Ho, et al.
Cancer Medicine|December 5, 2022
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/dayMatthew H Taylor, Sophie Leboulleux, Yury Panaseykin, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE<sub>2</sub>-receptor E-type 4 (EP4), in patients with advanced cancersDavid S Hong, Aparna Parikh, Geoffrey I Shapiro, et al.
JCO Precision Oncology|September 4, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for GlioblastomaErica L Carpenter, Jacob E Till, Dominique Ballinger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2022
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumorsYibo Yin, Jesse L Rodriguez, Nannan Li, et al.
Scientific Reports|February 28, 2024
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approachJun Guo, Anahita Fathi Kazerooni, Erik Toorens, et al.
Pain|May 16, 2006
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference valuesR Rolke, R Baron, C Maier, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 16, 2019
Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2T Reiff, H H Eckstein, U Mansmann, et al.
Pageof 40